VBI Vaccines

About:

VBI Vaccines is a commercial stage biopharmaceutical company.

Website: https://www.vbivaccines.com/

Twitter/X: vbivaccines

Top Investors: ARCH Venture Partners, Phoenix Financial, Perceptive Advisors, Brii Biosciences, OPKO Health

Description:

SciVac Therapeutics changes its name to VBI Vaccines Sci-B-Vac is a commercial stage hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus and is free of any next-generation adjuvant. Sci-B-Vac offers rapid onset of protection, high levels of anti-HBV antibodies, and can be administered at lower doses than competing HBV vaccines. Sci-B-Vac is approved in Israel and in 14 other countries and has demonstrated a favorable safety and efficacy profile in over 300,000 patients.